Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...

The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...

U.S. President Donald Trump has repeatedly mentioned pharmaceuticals as another industry that could be targeted by tariffs, ...

Alembic reported a 163% surge in consolidated net profit to Rs 26.09 crore, on a 47.3% jump in revenue from operations to Rs 57.92 crore in Q3 FY25 over Q3 FY24.

Gone are the days when private equity investments were considered entirely benign from an antitrust perspective. Over ...

Third Harmonic Bio shares dived 35% in premarket trading amid a broader evaluation of THB335. Shares were trading around $3.03. The stock is down 50% over the last year.

This initiative represents a key step in diversifying the Company's business ... investors to review its filings with the SEC and corporate announcements for the latest company updates. Jupiter ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug ...

Last accessed: January 2025. 7 Pharmaceutical Business Review. 2024. Leqembi gains approval for Alzheimer’s treatment in Israel. Last accessed: January 2025. 8 United Arab Emirates Ministry of ...